PMCID: PMC7507632
[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Kumar S., King E.C., Christison A.L., Kelly A.S., Ariza A.J., Borzutzky C., Cuda S., Kirk S., POWER Work Group Health Outcomes of Youth in Clinical Pediatric Weight Management Programs in POWER
Mechanism of Action: GHS-R1a Agonist Ipamorelin exerts its effects through selective agonism of the growth hormone secretagogue receptor type 1a (GHS-R1a) , also known as the ghrelin receptor
Natural killer cells in patients with severe chronic fatigue syndrome
doi: 10.23736/S2724-6507.20.03369-6 [DOI] [PubMed] [Google Scholar] 135
Clinicians may recommend: Gradual dose escalation to allow digestive adaptation Monitoring symptoms during each dose stage Reviewing other medications that may affect digestion Patients should never adjust their dose without medical guidance